Trials / Unknown
UnknownNCT00677638
Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease
Catheter-Based Transapical Implantation of the Ventor Embracer™ Heart Valve Prosthesis in Patients With Severe Aortic Valve Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Ventor Technologies · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
A prospective single arm study evaluating feasibility and safety of a catheter-based transapical implantation of the Ventor Embracer™ aortic valve bioprosthesis in patients with severe aortic valve disease, specifically aortic stenosis, who are at elevated risk for standard surgical valve replacement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ventor Embracer | Implantation of Ventor Embracer |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-01-01
- Completion
- 2014-12-01
- First posted
- 2008-05-14
- Last updated
- 2009-12-03
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00677638. Inclusion in this directory is not an endorsement.